Evolus (EOLS) Depreciation & Amortization (CF) (2017 - 2026)

Evolus (EOLS) posted Depreciation & Amortization (CF) of $2.3 million for Q1 2026, up 4.08% on a QoQ basis from $2.3 million in Q4 2025, and up 50.1% year-over-year from $1.6 million in Q1 2025.

Evolus (EOLS) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Evolus' Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $2.3 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 50.1% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (up 52.06% YoY) and the FY2025 annual result came in at $7.5 million, up 41.7% from the prior year.
  • Depreciation & Amortization (CF) was $2.3 million for Q1 2026 at Evolus, up from $2.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $2.3 million in Q1 2026 and bottomed at $853000.0 in Q2 2022.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) slumped 54.65% — and 2025, when it jumped 79.48%.
  • Evolus' Depreciation & Amortization (CF) stood at $1.0 million in 2022, then soared by 33.69% to $1.4 million in 2023, then gained by 0.07% to $1.4 million in 2024, then surged by 64.05% to $2.3 million in 2025, then grew by 4.08% to $2.3 million in 2026.
  • Business Quant data shows EOLS's Depreciation & Amortization (CF) at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn 2.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.35 Mn
Mar 31, 2026 2.35 Mn
Dec 31, 2025 2.25 Mn
Dec 31, 2025 2.25 Mn
Sep 30, 2025 1.95 Mn
Sep 30, 2025 1.95 Mn
Jun 30, 2025 1.74 Mn
Jun 30, 2025 1.74 Mn
Mar 31, 2025 1.56 Mn
Mar 31, 2025 1.56 Mn
Dec 31, 2024 1.37 Mn
Dec 31, 2024 1.37 Mn
Sep 30, 2024 1.09 Mn
Sep 30, 2024 1.09 Mn
Jun 30, 2024 1.43 Mn
Jun 30, 2024 1.43 Mn
Mar 31, 2024 1.41 Mn
Mar 31, 2024 1.41 Mn
Dec 31, 2023 1.37 Mn
Dec 31, 2023 1.37 Mn